Please login to the form below

Not currently logged in


This page shows the latest canakinumab news and features for those working in and with pharma, biotech and healthcare.

Novartis in-licenses Akcea’s novel cardiovascular therapy

Novartis in-licenses Akcea’s novel cardiovascular therapy

The difficulty of developing and commercialising new cardiovascular treatments has been illustrated by two other Novartis drugs  - Entresto and canakinumab. ... The new development deal could help plug a gap left by canakinumab in its late-stage CVD

Latest news

More from news
Approximately 3 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...